Status:
COMPLETED
Testosterone, Cognition, Ageing, and Cancer
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Cancer-related Cognitive Impairment
Eligibility:
MALE
18+ years
Brief Summary
The primary aim of the study is - in a prospective controlled design - to examine whether treatment-induced decreases in testosterone acts as a mechanism of cancer-related cognitive impairment (CRCI) ...
Detailed Description
The study will include three groups with a total of 120 participants: A) Forty testicular cancer patients will be included and examined 1) shortly after orchiectomy and prior to any further treatment ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of testicular cancer
- Confirmed diagnosis of prostate cancer and prescription of medical castration and radiotherapy
Exclusion
- Previous cancer disease
- Previous central nervous system disease
- Brain metastases
- Severe psychiatric disease (e.g., schizophrenia, major depressive disorder)
- Insufficient Danish proficiency for neuropsychological testing
Key Trial Info
Start Date :
February 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT03452436
Start Date
February 12 2018
End Date
March 1 2020
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200